國家衛生研究院 NHRI:Item 3990099045/9638
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 908407      Online Users : 991
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9638


    Title: EBV reactivation as a target of luteolin to repress NPC tumorigenesis
    Authors: Wu, CC;Fang, CY;Hsu, HY;Chuang, HY;Cheng, YJ;Chen, YJ;Chou, SP;Huang, SY;Lin, SF;Chang, Y;Tsai, CH;Chen, JY
    Contributors: National Institute of Cancer Research;Division of Infectious Diseases
    Abstract: Nasopharyngeal carcinoma (NPC) is a malignancy derived from the epithelial cells of the nasopharynx. Although a combination of radiotherapy with chemotherapy is effective for therapy, relapse and metastasis after remission remain major causes of mortality. Epstein-Barr virus (EBV) is believed to be one of causes of NPC development. We demonstrated previously that EBV reactivation is important for the carcinogenesis of NPC. We sought, therefore, to determine whether EBV reactivation can be a target for retardation of relapse of NPC. After screening, we found luteolin is able to inhibit EBV reactivation. It inhibited EBV lytic protein expression and repressed the promoter activities of two major immediate-early genes, Zta and Rta. Furthermore, luteolin was shown to reduce genomic instability induced by recurrent EBV reactivation in NPC cells. EBV reactivation-induced NPC cell proliferation and migration, as well as matrigel invasiveness, were also repressed by luteolin treatment. Tumorigenicity in mice, induced by EBV reactivation, was decreased profoundly following luteolin administration. Together, these results suggest that inhibition of EBV reactivation is a novel approach to prevent the relapse of NPC.
    Date: 2016-03-08
    Relation: Oncotarget. 2016 Mar 8;7(14):18999-19017.
    Link to: http://dx.doi.org/10.18632/oncotarget.7967
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000375699000138
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84975494885
    Appears in Collections:[Jen-Yang Chen] Periodical Articles
    [Su-Fang Lin] Periodical Articles
    [Yao Chang] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PUB26967558.pdf5088KbAdobe PDF497View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback